Results 131 to 140 of about 211,160 (222)

Uterine sarcoma: A 10-year retrospective analysis of clinicopathological and prognostic factors of surgically treated cases. [PDF]

Ecancermedicalscience
David J, Arora R, Vasanth A, Burde K, Patel B, Parekh C.   +5 more
europepmc   +1 more source

A Case of Uterine Sarcoma: The Impact of Insurance Policy on Timely Access to Hysterectomy

Background: Uterine sarcoma, a uterine cancer subtype, is a rare, aggressive malignancy with non-specific symptoms, complicating early diagnosis and management.
Karki, Sabin, Cook, Myanna, Bell, Kameron, Sakbun, Vannara   +3 more
core   +1 more source

SMARCA4-deficient undifferentiated uterine sarcoma: A case report and literature review. [PDF]

Medicine (Baltimore)
Wang Y, Sun Y, Jiang Y, Chen X, Dai H.
europepmc   +1 more source

Uterine sarcoma: almost more tumor than patient. [PDF]

Arch Gynecol Obstet, 2023
Ellis LB, Jones B, Yagel I, Walker-Jacobs A, Galani A, Hamlyn L, Kyrgiou M.   +6 more
europepmc   +1 more source

Undifferentiated uterine sarcoma : experience of a single center. [PDF]

World J Surg Oncol
Yuan H, Wang T, Li N, Yao H.
europepmc   +1 more source

β-catenin is a Potential Prognostic Biomarker in Uterine Sarcoma. [PDF]

Technol Cancer Res Treat
Cai Y, Wang Y, Yang L, Huang Y, Chen MJ, Zhang C, Jin SH, Frey B, Gaipl US, Ma H, Zhou JG.   +10 more
europepmc   +1 more source

Orosomucoid 1 is a Potential Prognostic Biomarker for Uterine Sarcoma. [PDF]

Technol Cancer Res Treat
Yuan D, Huang Y, Cai Y, Zhang C, Wang JJ, Zhou JG.   +5 more
europepmc   +1 more source

Retraction: FGF23 is a potential prognostic biomarker in uterine sarcoma. [PDF]

Technol Cancer Res Treat
europepmc   +1 more source

Complete response of somatic <i>POLE</i>-ultramutated recurrent undifferentiated uterine sarcoma to pembrolizumab and concurrent radiotherapy. [PDF]

Gynecol Oncol Rep
Charewycz NE, Hsu IJ, Lu K, Fuh K, Chen LM, Monga V, Cham S.   +6 more
europepmc   +1 more source

Advancement in Multi-omics approaches for Uterine Sarcoma. [PDF]

Biomark Res
Wang W, Hu Y, Fu F, Ren W, Wang T, Wang S, Li Y.   +6 more
europepmc   +1 more source